Submission rejected on 1 June 2024 by
Twinkle1990 (
talk). This topic is not sufficiently notable for inclusion in Wikipedia. Rejected by Twinkle1990 33 days ago. Last edited by Theroadislong 14 days ago. |
Submission declined on 31 May 2024 by
Twinkle1990 (
talk). This submission's references do not show that the subject
qualifies for a Wikipedia article—that is, they do not show significant coverage (not just passing mentions) about the subject in published,
reliable,
secondary sources that are
independent of the subject (see the
guidelines on the notability of people). Before any resubmission, additional references meeting these criteria should be added (see
technical help and learn about
mistakes to avoid when addressing this issue). If no additional references exist, the subject is not suitable for Wikipedia. Declined by
Twinkle1990 34 days ago. |
Submission declined on 27 May 2024 by
Liance (
talk). This submission is not adequately supported by
reliable sources. Reliable sources are required so that information can be
verified. If you need help with referencing, please see
Referencing for beginners and
Citing sources. The content of this submission includes material that does not meet Wikipedia's
minimum standard for inline citations. Please
cite your sources using
footnotes. For instructions on how to do this, please see
Referencing for beginners. Thank you. Declined by
Liance 38 days ago. |
Submission declined on 26 May 2024 by
Twinkle1990 (
talk). This submission's references do not show that the subject
qualifies for a Wikipedia article—that is, they do not show significant coverage (not just passing mentions) about the subject in published,
reliable,
secondary sources that are
independent of the subject (see the
guidelines on the notability of people). Before any resubmission, additional references meeting these criteria should be added (see
technical help and learn about
mistakes to avoid when addressing this issue). If no additional references exist, the subject is not suitable for Wikipedia. Declined by
Twinkle1990 39 days ago. |
Submission declined on 15 April 2024 by
Paul W (
talk). This submission's references do not show that the subject
qualifies for a Wikipedia article—that is, they do not show significant coverage (not just passing mentions) about the subject in published,
reliable,
secondary sources that are
independent of the subject (see the
guidelines on the notability of people). Before any resubmission, additional references meeting these criteria should be added (see
technical help and learn about
mistakes to avoid when addressing this issue). If no additional references exist, the subject is not suitable for Wikipedia. This submission is not adequately supported by
reliable sources. Reliable sources are required so that information can be
verified. If you need help with referencing, please see
Referencing for beginners and
Citing sources. Declined by
Paul W 2 months ago. |
Submission declined on 12 April 2024 by
The Herald (
talk). This submission is not adequately supported by
reliable sources. Reliable sources are required so that information can be
verified. If you need help with referencing, please see
Referencing for beginners and
Citing sources. This submission's references do not show that the subject
qualifies for a Wikipedia article—that is, they do not show significant coverage (not just passing mentions) about the subject in published,
reliable,
secondary sources that are
independent of the subject (see the
guidelines on the notability of people). Before any resubmission, additional references meeting these criteria should be added (see
technical help and learn about
mistakes to avoid when addressing this issue). If no additional references exist, the subject is not suitable for Wikipedia. Declined by
The Herald 2 months ago. |
Submission declined on 10 April 2024 by
Vanderwaalforces (
talk). This submission's references do not show that the subject
qualifies for a Wikipedia article—that is, they do not show significant coverage (not just passing mentions) about the subject in published,
reliable,
secondary sources that are
independent of the subject (see the
guidelines on the notability of people). Before any resubmission, additional references meeting these criteria should be added (see
technical help and learn about
mistakes to avoid when addressing this issue). If no additional references exist, the subject is not suitable for Wikipedia. Declined by
Vanderwaalforces 2 months ago. |
Submission declined on 5 April 2024 by
Qcne (
talk). This submission is not adequately supported by
reliable sources. Reliable sources are required so that information can be
verified. If you need help with referencing, please see
Referencing for beginners and
Citing sources. Declined by
Qcne 2 months ago. |
Submission declined on 28 March 2024 by
Paul W (
talk). The content of this submission includes material that does not meet Wikipedia's
minimum standard for inline citations. Please
cite your sources using
footnotes. For instructions on how to do this, please see
Referencing for beginners. Thank you. Declined by
Paul W 3 months ago. |
Roberto Giovanni Carbone [1] (born 6 September 1954) is an Italian scientist and clinician, studying the mechanisms and treatment of pulmonary fibrosis, pulmonary hypertension and lung transplantation.
Born in Genoa, His father Giuseppe Carbone [2] was deputy managing executive director of Gilardini Company (President and CEO Carlo De Benedetti). Carbone graduated from the University of Genoa [3] in Medicine and Surgery in 1983 and registered with General Medical Council in 2003. [4] He obtained a master's degrees in pulmonary hypertension from the University of Michigan and a further master's in respiratory medicine and bronchology from the National Heart and Lung Institute Royal Brompton Hospital Imperial & College in London [5], in asthma at the University of Denver, in Pneumology at University of Montpellier and in asthma and COPD from the University of Ferrara.
After specializing in pulmonary diseases and respiratory pathophysiology, he undertook clinical training at the regional Hospital of Aosta as deputy head physician. [6] [7]
From 2020 to 2022 he worked as clinical researcher at University of Genoa. [8]
In 2023 he became a fellow of the Royal Society of Medicine, London. [9] [10]
He was awarded an honorary professorship in 2022 and is a senior consultant cardio-respiratory physician at University of Genoa. [11]
His research initially focused on the study of alpha-1 antitrypsin deficiency pulmonary emphysema, and urinary degradation products (desmosin) and prolastin treatment working in the lab of Gordon L. Snider ( Harvard University). He dedicated himself to the study of lung cancer, creating the first Italian Cancer Registry with the patronage of the Istituto Superiore di Sanità in the figure of Marco Geddes di Filicaja, at IST (Scientific Institute of Tumors) in Genoa under the direction of Leonardo Santi.
He studied the pathologies of asbestos, such as pleural mesothelioma at Scansetti Interdepartmental Center in Turin where he collaborated with Roberto Compagnoni of University of Turin and Bice Fubini also enrolled in the Academy of Sciences of Turin. Subsequently he studied the role of neuropeptides (neurotensin) [12] in asthma adrenergic regulation with Giovanni Bottino (University of Genoa). [13] He went on to win the first prize as speaker and author in Italian CHEST congress ( American College of Chest Physicians). [14] The study entitled In vivo the micro-environmental reactivity in asthmatic [15] took place over a period of 15 years and was the first in the world to evaluate bronchial hyperreactivity in asthmatic subjects in vivo and in vitro and to do research on the use of new radioactive isotopes as indium-111 and octreotide (labeled somatostatin) in interstitial lung diseases and sarcoidosis. [16]
His first book entitled Pulmonary Arterial Hypertension and Interstitial Lung Diseases published in 2009 is held in Capitol Hill Library [17] [18](Washington D.C.), at MIT in Boston, at the National Institute of Health, at Moscow University and is also in widespread readership in China. [19] This book is a seminal text which introduced conjoined treatment of pulmonary hypertension and pulmonary fibrosis since the International Congress "World Association Sarcoidosis and Other Granulomatous Disorders' ' (WASOG) in Denver in 2005. [20] His third book entitled Lung Transplantation - Evolving Knowledge and New Horizons, a collaboration with Mario Viganò contains a first chapter entitled "The History of Lung Transplantation" [21] which is considered by the Book Authority one of the best books on thoracic surgery of all time. In 2023 this is positioned fifty-second in the "Best Thoracic Surgery eBooks of all time" ranking. [22]
In 2007, William (Bill) D. Travis, directed Carbone to the study of pneumonia of the pulmonary interstitium in the lung deep area which was not attributable to inflammation bacteria or viruses, rather of unknown cause. Carbone discovered through the study of Indium [23] and pulmonary hypertension that fibrotic pneumonia has a high mortality rate. [24]
Since 2017 He's Member of Global IPF Collaborative Network: a Platform for IPF Genetics for University of Genoa, Principal Investigator Prof. David Schwartz MD from University of Colorado Anschutz Medical Campus. Scope of the study is further understand the genetics of IPF by collecting more than 10,000 ethnically diverse cases of Idiopathic Pulmonary Fibrosis (IPF) with the collaboration of 70 international investigators (40 sites). [25] [26]
Carbone is the author of over 150 publications in peer-reviewed journals. [27]
He was a member of the editorial board of the scientific journal CHEST [28] and is an associate editor of the journal Frontiers. [29] He has published 5 books [30] in English [31] as a scientific editor. [32] Scopus reported approximately 1000 citations. [33] [34]
Submission rejected on 1 June 2024 by
Twinkle1990 (
talk). This topic is not sufficiently notable for inclusion in Wikipedia. Rejected by Twinkle1990 33 days ago. Last edited by Theroadislong 14 days ago. |
Submission declined on 31 May 2024 by
Twinkle1990 (
talk). This submission's references do not show that the subject
qualifies for a Wikipedia article—that is, they do not show significant coverage (not just passing mentions) about the subject in published,
reliable,
secondary sources that are
independent of the subject (see the
guidelines on the notability of people). Before any resubmission, additional references meeting these criteria should be added (see
technical help and learn about
mistakes to avoid when addressing this issue). If no additional references exist, the subject is not suitable for Wikipedia. Declined by
Twinkle1990 34 days ago. |
Submission declined on 27 May 2024 by
Liance (
talk). This submission is not adequately supported by
reliable sources. Reliable sources are required so that information can be
verified. If you need help with referencing, please see
Referencing for beginners and
Citing sources. The content of this submission includes material that does not meet Wikipedia's
minimum standard for inline citations. Please
cite your sources using
footnotes. For instructions on how to do this, please see
Referencing for beginners. Thank you. Declined by
Liance 38 days ago. |
Submission declined on 26 May 2024 by
Twinkle1990 (
talk). This submission's references do not show that the subject
qualifies for a Wikipedia article—that is, they do not show significant coverage (not just passing mentions) about the subject in published,
reliable,
secondary sources that are
independent of the subject (see the
guidelines on the notability of people). Before any resubmission, additional references meeting these criteria should be added (see
technical help and learn about
mistakes to avoid when addressing this issue). If no additional references exist, the subject is not suitable for Wikipedia. Declined by
Twinkle1990 39 days ago. |
Submission declined on 15 April 2024 by
Paul W (
talk). This submission's references do not show that the subject
qualifies for a Wikipedia article—that is, they do not show significant coverage (not just passing mentions) about the subject in published,
reliable,
secondary sources that are
independent of the subject (see the
guidelines on the notability of people). Before any resubmission, additional references meeting these criteria should be added (see
technical help and learn about
mistakes to avoid when addressing this issue). If no additional references exist, the subject is not suitable for Wikipedia. This submission is not adequately supported by
reliable sources. Reliable sources are required so that information can be
verified. If you need help with referencing, please see
Referencing for beginners and
Citing sources. Declined by
Paul W 2 months ago. |
Submission declined on 12 April 2024 by
The Herald (
talk). This submission is not adequately supported by
reliable sources. Reliable sources are required so that information can be
verified. If you need help with referencing, please see
Referencing for beginners and
Citing sources. This submission's references do not show that the subject
qualifies for a Wikipedia article—that is, they do not show significant coverage (not just passing mentions) about the subject in published,
reliable,
secondary sources that are
independent of the subject (see the
guidelines on the notability of people). Before any resubmission, additional references meeting these criteria should be added (see
technical help and learn about
mistakes to avoid when addressing this issue). If no additional references exist, the subject is not suitable for Wikipedia. Declined by
The Herald 2 months ago. |
Submission declined on 10 April 2024 by
Vanderwaalforces (
talk). This submission's references do not show that the subject
qualifies for a Wikipedia article—that is, they do not show significant coverage (not just passing mentions) about the subject in published,
reliable,
secondary sources that are
independent of the subject (see the
guidelines on the notability of people). Before any resubmission, additional references meeting these criteria should be added (see
technical help and learn about
mistakes to avoid when addressing this issue). If no additional references exist, the subject is not suitable for Wikipedia. Declined by
Vanderwaalforces 2 months ago. |
Submission declined on 5 April 2024 by
Qcne (
talk). This submission is not adequately supported by
reliable sources. Reliable sources are required so that information can be
verified. If you need help with referencing, please see
Referencing for beginners and
Citing sources. Declined by
Qcne 2 months ago. |
Submission declined on 28 March 2024 by
Paul W (
talk). The content of this submission includes material that does not meet Wikipedia's
minimum standard for inline citations. Please
cite your sources using
footnotes. For instructions on how to do this, please see
Referencing for beginners. Thank you. Declined by
Paul W 3 months ago. |
Roberto Giovanni Carbone [1] (born 6 September 1954) is an Italian scientist and clinician, studying the mechanisms and treatment of pulmonary fibrosis, pulmonary hypertension and lung transplantation.
Born in Genoa, His father Giuseppe Carbone [2] was deputy managing executive director of Gilardini Company (President and CEO Carlo De Benedetti). Carbone graduated from the University of Genoa [3] in Medicine and Surgery in 1983 and registered with General Medical Council in 2003. [4] He obtained a master's degrees in pulmonary hypertension from the University of Michigan and a further master's in respiratory medicine and bronchology from the National Heart and Lung Institute Royal Brompton Hospital Imperial & College in London [5], in asthma at the University of Denver, in Pneumology at University of Montpellier and in asthma and COPD from the University of Ferrara.
After specializing in pulmonary diseases and respiratory pathophysiology, he undertook clinical training at the regional Hospital of Aosta as deputy head physician. [6] [7]
From 2020 to 2022 he worked as clinical researcher at University of Genoa. [8]
In 2023 he became a fellow of the Royal Society of Medicine, London. [9] [10]
He was awarded an honorary professorship in 2022 and is a senior consultant cardio-respiratory physician at University of Genoa. [11]
His research initially focused on the study of alpha-1 antitrypsin deficiency pulmonary emphysema, and urinary degradation products (desmosin) and prolastin treatment working in the lab of Gordon L. Snider ( Harvard University). He dedicated himself to the study of lung cancer, creating the first Italian Cancer Registry with the patronage of the Istituto Superiore di Sanità in the figure of Marco Geddes di Filicaja, at IST (Scientific Institute of Tumors) in Genoa under the direction of Leonardo Santi.
He studied the pathologies of asbestos, such as pleural mesothelioma at Scansetti Interdepartmental Center in Turin where he collaborated with Roberto Compagnoni of University of Turin and Bice Fubini also enrolled in the Academy of Sciences of Turin. Subsequently he studied the role of neuropeptides (neurotensin) [12] in asthma adrenergic regulation with Giovanni Bottino (University of Genoa). [13] He went on to win the first prize as speaker and author in Italian CHEST congress ( American College of Chest Physicians). [14] The study entitled In vivo the micro-environmental reactivity in asthmatic [15] took place over a period of 15 years and was the first in the world to evaluate bronchial hyperreactivity in asthmatic subjects in vivo and in vitro and to do research on the use of new radioactive isotopes as indium-111 and octreotide (labeled somatostatin) in interstitial lung diseases and sarcoidosis. [16]
His first book entitled Pulmonary Arterial Hypertension and Interstitial Lung Diseases published in 2009 is held in Capitol Hill Library [17] [18](Washington D.C.), at MIT in Boston, at the National Institute of Health, at Moscow University and is also in widespread readership in China. [19] This book is a seminal text which introduced conjoined treatment of pulmonary hypertension and pulmonary fibrosis since the International Congress "World Association Sarcoidosis and Other Granulomatous Disorders' ' (WASOG) in Denver in 2005. [20] His third book entitled Lung Transplantation - Evolving Knowledge and New Horizons, a collaboration with Mario Viganò contains a first chapter entitled "The History of Lung Transplantation" [21] which is considered by the Book Authority one of the best books on thoracic surgery of all time. In 2023 this is positioned fifty-second in the "Best Thoracic Surgery eBooks of all time" ranking. [22]
In 2007, William (Bill) D. Travis, directed Carbone to the study of pneumonia of the pulmonary interstitium in the lung deep area which was not attributable to inflammation bacteria or viruses, rather of unknown cause. Carbone discovered through the study of Indium [23] and pulmonary hypertension that fibrotic pneumonia has a high mortality rate. [24]
Since 2017 He's Member of Global IPF Collaborative Network: a Platform for IPF Genetics for University of Genoa, Principal Investigator Prof. David Schwartz MD from University of Colorado Anschutz Medical Campus. Scope of the study is further understand the genetics of IPF by collecting more than 10,000 ethnically diverse cases of Idiopathic Pulmonary Fibrosis (IPF) with the collaboration of 70 international investigators (40 sites). [25] [26]
Carbone is the author of over 150 publications in peer-reviewed journals. [27]
He was a member of the editorial board of the scientific journal CHEST [28] and is an associate editor of the journal Frontiers. [29] He has published 5 books [30] in English [31] as a scientific editor. [32] Scopus reported approximately 1000 citations. [33] [34]